Related Experiment Video
Updated: Jan 5, 2026

Acquisition of Resting-State Functional Magnetic Resonance Imaging Data in the Rat
Published on: August 28, 2021
Intranasal dexmedetomidine in pediatrics: update of current knowledge
Maria C Mondardini1, Angela Amigoni2, Paolo Cortellazzi3
1Pediatric Intensive Care Unit, Department of Woman's, Child's and Urological Diseases, S. Orsola-Malpighi Polyclinic University Hospital, Bologna, Italy - mariacristina.mondardini@aosp.bo.it.
Abstract:
Intranasal dexmedetomidine, although still off-label, recently boasted an increasing consensus for different uses, namely, in diagnostic non-painful procedures, in painful procedures and in surgical premedication. However, at present, there is no consensus regarding indications, dosage and timing for administration. This article aims to provide a comprehensive literature analysis and summarize the more recent evidence of research on pediatric intranasal dexmedetomidine, in the effort to better delineate usefulness and limits for each specific indication. In summary, available pediatric evidence confirms efficacy and safety of dexmedetomidine for intranasal administration. Pharmacological profile for the various pediatric ages and procedures still needs quality studies and pharmacokinetic in-depth analysis.
Related Concept Videos
Parenteral Anesthetics: Overview
Inhalational Anesthetics: Overview
Pharmacokinetics in Pediatric Patients: Drug Excretion
Drug Dosing: Infants and Children
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Drug Delivery: Enteral Route

